Form4insider filings, from the source

SEC Form 4 · accession 0000950103-18-003689

CASI Pharmaceuticals, Inc. · CASI

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Quan Zhou
Director · 10% Owner
Chi Sing Ho
10% Owner
Period of report
Mar 21, 2018
Accepted (ET)
Mar 23, 2018 · 3:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000895051

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF3,F1Mar 21, 2018P2,882,098$3.19A9,126,375D
Common StockF3,F2Mar 21, 2018P204,320$3.19A646,995ISee Explanation of Responses

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
WarrantF3,F1$3.69Mar 21, 2018P1,152,839ASep 17, 2018Mar 21, 2023Common Stock1,152,8391,152,839D
WarrantF3,F2$3.69Mar 21, 2018P1,152,839ASep 17, 2018Mar 21, 2023Common Stock81,72881,728I

Explanation of responses